CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: To test this hypothesis, we performed a cell cycle analysis of the CD34+ cells by the AO flow cytometric technique demonstrating a larger pool of quiescent (dormant) cells in CD34+ cells from CP-CML with respect to normal ones.